US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

FDA Commissioner on steps to promote development of generic versions of opioids formulated to deter abuse
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse